logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

CHONGQING M&E (02722) will pay an interim dividend of RMB0.02 per share on December 21.

date
12:20 19/11/2026
avatar
GMT Eight
CHONGQING M&E (02722) announced that it will pay an interim dividend of RMB0.02 per share for the six months ended June 30, 2026, on December 21, 2026.
CHONGQING M&E (02722) announced that it will pay an interim dividend of RMB0.02 per share for the six months ended June 30, 2026, on December 21, 2026.
Related Articles
HK Stock
SA SA INT'L (00178) will pay an interim dividend of HK$0.04 per share on December 18.
HK Stock
SSY GROUP (02005): Low-calcium Peritoneal Dialysis Solution (Bicarbonate G1.5%) and Other Drugs Obtain Drug Production Registration Approval
HK Stock
SA SA INT'L (00178) announces interim results, profit attributable to shareholders HK$170 million, up 239.14% year-on-year; sales performance in core markets Hong Kong and Macau improved significantly.
SA SA INT'L (00178) will pay an interim dividend of HK$0.04 per share on December 18.
HK Stock
SSY GROUP (02005): Low-calcium Peritoneal Dialysis Solution (Bicarbonate G1.5%) and Other Drugs Obtain Drug Production Registration Approval
HK Stock
SA SA INT'L (00178) announces interim results, profit attributable to shareholders HK$170 million, up 239.14% year-on-year; sales performance in core markets Hong Kong and Macau improved significantly.
HK Stock
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.